| Talk title | AI Directed CTL Vaccine Design for a Novel Synthetic Vaccine Platform |
| Speaker | Dr. Reid M. Rubsamen CEO, Flow Pharma, Inc |
| Date & Time | 31 August 2018 (Friday) 14:30-15:30 |
| Venue | Room G004, E12 Building (University of Macau) |
| Abstract | Flow Pharma is a San Francisco based biotechnology company using AI-augmented proteomics analytical techniques to select Class I epitopes for inclusion into a novel synthetic vaccine platform for immuno oncology and infectious disease applications. Lead products under development are FlowVax HPV for treating women with advanced cervical cancer and FlowVax EBOV for protection against Ebola infection. |
